Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boren Jiang

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Frontiers in Endocrinology|April 12, 2021
Association of Insulin Resistance and β-cell Function With Bone Turnover Biomarkers in Dysglycemia PatientsHui Guo, Chiyu Wang, Boren Jiang, et al.
Endocrine Research|June 22, 2023
T Cell Subsets are Associated with Clinical Activity and Efficacy of 4.5g Intravenous Glucocorticoid for Moderate-To-Severe Thyroid-Associated OphthalmopathyHuixia Li, Bin Wang, Qin Li, et al.
Clinical and Translational Science|March 20, 2021
Influence of 4-week or 12-week glucocorticoid treatment on metabolic changes in patients with active moderate-to-severe thyroid-associated ophthalmopathyXiaoman Chen, Buatikamu Abudukerimu, Qin Li, et al.
The Journal of Infection|October 18, 2022
Clinical features and outcomes of hospitalized patients with COVID-19 during the Omicron wave in Shanghai, ChinaBin Wang, Yuefeng Yu, Yuetian Yu, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Frontiers in Endocrinology|April 12, 2021
Association of Insulin Resistance and β-cell Function With Bone Turnover Biomarkers in Dysglycemia PatientsHui Guo, Chiyu Wang, Boren Jiang, et al.
Endocrine Research|June 22, 2023
T Cell Subsets are Associated with Clinical Activity and Efficacy of 4.5g Intravenous Glucocorticoid for Moderate-To-Severe Thyroid-Associated OphthalmopathyHuixia Li, Bin Wang, Qin Li, et al.
Clinical and Translational Science|March 20, 2021
Influence of 4-week or 12-week glucocorticoid treatment on metabolic changes in patients with active moderate-to-severe thyroid-associated ophthalmopathyXiaoman Chen, Buatikamu Abudukerimu, Qin Li, et al.
The Journal of Infection|October 18, 2022
Clinical features and outcomes of hospitalized patients with COVID-19 during the Omicron wave in Shanghai, ChinaBin Wang, Yuefeng Yu, Yuetian Yu, et al.
Pageof 4